Nevakar Injectables Receives U.S. FDA Approval of Ready-to-Use Ephedrine Injection in…
BRIDGEWATER, N.J., April 28, 2022 (GLOBE NEWSWIRE) -- Nevakar Injectables Inc. (“Nevakar”), a wholly owned subsidiary of Nevakar, Inc., is a biopharmaceutical company developing multiple…